Literature DB >> 28582648

Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis.

Ze-Bin Luo1, Yuan-Yuan Chen1, Xiao-Jun Xu1, Ning Zhao1, Yong-Min Tang2.   

Abstract

Hemophagocytic lymphohistiocytosis is a rapidly progressing and fatal disease. Early identification of early death for HLH patients based on the laboratory findings at the time of diagnosis could improve the overall survival. A retrospective study was performed on 95 Chinese pediatric patients with HLH. Patients' data including clinical features and laboratory findings at diagnosis were collected. In a multivariate Cox proportional hazard regression model analysis, albumin≤27.75g/L (hazard ratio (HR)=11.82, 95% confidence interval (CI) 2.58-54.23; P=0.001), LDH≥3707.5 U/L (HR=4.15, 95%CI 1.43-12.01; P=0.009), and IL-10≥456pg/ml (HR=12.39, 95%CI 1.59-96.79; P=0.016) at diagnosis were independent prognostic factors of early death. The risk of early death was 33-fold increase in patients with three risk factors (HR=33.33; 95%CI 8.40-125.00; P<0.001), and 12-fold increase in patients with two risk factors (HR=12.80; 95%CI 2.34-69.80; P=0.002) when compared to it in patients with zero to one risk factor. Our results reveal that HLH patients with the risk of early death can be identified by laboratory findings at diagnosis, which may help guide the treatment decision making for this disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Cytokine; Early death; Hemophagocytic lymphohistiocytosis; Liver damage

Mesh:

Substances:

Year:  2017        PMID: 28582648     DOI: 10.1016/j.cyto.2017.03.013

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Elevated serum myoglobin levels at hospital admission and the risk of early death among patients with hemophagocytic lymphohistiocytosis: evidence from 155 pediatric patients.

Authors:  Xun Li; Haipeng Yan; Xinping Zhang; Jiaotian Huang; Shi-Ting Xiang; Zhenya Yao; Ping Zang; Desheng Zhu; Zhenghui Xiao; Xiulan Lu
Journal:  Ann Hematol       Date:  2020-03-27       Impact factor: 3.673

2.  Hepatobiliary Dysfunction and Disseminated Intravascular Coagulation Increase Risk of Mortality in Pediatric Hemophagocytic Lymphohistiocytosis.

Authors:  Jordana Goldman; Moreshwar S Desai; Kenneth L McClain; M Hossein Tcharmtchi; Curtis E Kennedy; Kathleen Thompson; Fong Lam; Dalia A Bashir; Ivan K Chinn; Baruch R Goldberg; Carl E Allen; Trung C Nguyen
Journal:  Pediatr Crit Care Med       Date:  2018-10       Impact factor: 3.971

3.  Clinical Features and Prognostic Factors of Early Outcome in Pediatric Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis of 227 Cases.

Authors:  Yong-Hai Zhou; Xin-Ru Han; Fang-Qing Xia; Neha-Devi Poonit; Li Liu
Journal:  J Pediatr Hematol Oncol       Date:  2022-01-01       Impact factor: 1.289

4.  Fulfillment status of hypertriglyceridemia and hypofibrinogenemia in children with hemophagocytic lymphohistiocytosis and risks of multiple organ dysfunction syndrome and early mortality.

Authors:  Xun Li; Haipeng Yan; Ting Luo; Zhenghui Xiao; Ling Gong; Jiaotian Huang; Xinping Zhang; Mincui Zheng; Zhenya Yao; Ping Zang; Desheng Zhu; Xiulan Lu
Journal:  Orphanet J Rare Dis       Date:  2022-04-11       Impact factor: 4.123

5.  Central nervous system involvement and thrombocytopenia as predictors of mortality in children with hemophagocytic lymphohistiocytosis.

Authors:  Saralee Harnchoowong; Sirisucha Soponkanaporn; Soamarat Vilaiyuk; Butsabong Lerkvaleekul; Samart Pakakasama
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

6.  Development of a screening score for Hemophagocytic Lymphohistiocytosis among pediatric patients with acute infection of Epstein-Barr virus.

Authors:  Xun Li; Haipeng Yan; Zhenghui Xiao; Ting Luo; Longlong Xie; Yufan Yang; Ling Gong; Zhexuan Tang; Jiaotian Huang; Xinping Zhang; Mincui Zheng; Zhenya Yao; Ping Zang; Desheng Zhu; Xiulan Lu
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

7.  Clinical profiles and risk factors of 7-day and 30-day mortality among 160 pediatric patients with hemophagocytic lymphohistiocytosis.

Authors:  Xun Li; Haipeng Yan; Xinping Zhang; Jiaotian Huang; Shi-Ting Xiang; Zhenya Yao; Ping Zang; Desheng Zhu; Zhenghui Xiao; Xiulan Lu
Journal:  Orphanet J Rare Dis       Date:  2020-08-31       Impact factor: 4.123

8.  Diagnostic Time Lag of Pediatric Haemophagocytic Lymphohistiocytosis and Patient Characteristics: A Retrospective Cohort Study.

Authors:  Xun Li; Haipeng Yan; Zhenghui Xiao; Xinping Zhang; Jiaotian Huang; Shi-Ting Xiang; Mincui Zheng; Zhenya Yao; Ping Zang; Desheng Zhu; Liping Li; Xiulan Lu
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418

9.  Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study.

Authors:  Mahdi Shahriari; Mohammadreza Bordbar; Hadi Mottaghipisheh; Kurosh Kalantar; Ali Amanati; Mansoureh Shokripour; Omid Reza Zekavat; Soheila Zareifar; Mehran Karimi; Sezaneh Haghpanah
Journal:  BMC Infect Dis       Date:  2021-08-02       Impact factor: 3.090

10.  Increased levels of serum interleukin-10 are associated with poor outcome in adult hemophagocytic lymphohistiocytosis patients.

Authors:  Yulan Zhou; Fancong Kong; Shixuan Wang; Min Yu; Yawen Xu; Jing Kang; Songtao Tu; Fei Li
Journal:  Orphanet J Rare Dis       Date:  2021-08-04       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.